MedPath

Effect of a herbal product on men's androgenic alopecia

Phase 3
Conditions
Androgenic alopecia.
L64.9
Androgenic alopecia, unspecified
Registration Number
IRCT20201010048979N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
46
Inclusion Criteria

Men aged 18 to 60 years old
Type 1 to 3 hair loss according to the Hamilton Hair Loss Criterion that has lasted more than 6 months
Patient approval to participate in the study

Exclusion Criteria

Having sensitivity to any of the components use in this study
History of G6PD
Records of using any typical products to prevent hair loss or stimulate hair growth in the past 2 months
Utilizing 5 a reductase inhibitors in the past 2 months
Records of taking anti-androgenic drugs in the past 2 months
Records of systemically taken steroids for more than 14 days in the past 2 months
Any records of uncontrolled blood pressure or hypotension
Any active diseases in the head including scalp infection in the past 6 months
Records of any types of cancer or autoimmune diseases
Any records of hair transplantation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of hair strands. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Terminal hair to Volos hair. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Hairs' diameter. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Physician satisfaction with treatment. Timepoint: Before intervention, 6 and 12 weeks after the intervention. Method of measurement: questionnaire.;Patient satisfaction with treatment. Timepoint: Before intervention, 6 and 12 weeks after the intervention. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath